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Pathogen Causing Acute
Respiratory Distress
Syndrome
To the Editor—Viral respiratory in-
fections represent a frequent cause of
intensive care unit (ICU) admissions in
children and impose a considerable
burden worldwide [1]. The main
pathogens are respiratory syncytial virus
(RSV) and seasonal influenza. Human
metapneumovirus (hMPV) is an
emerging pathogen of the Para-
myxoviridae family causing acute bron-
chiolitis-like respiratory illness in
children [2]. Williams et al [2] have re-
cently reported an annual rate of hMPV-
associated hospitalizations of 1.2 per
1000 hospitalized children ,5 years of
age in the United States, confirming that
hMPV contributes significantly to re-
spiratory morbidity with a similar im-
pact as influenza. In their study, most
hMPV-infected children had a relatively
mild course, with only 1 participant
(3%) requiring ICU admission. We
would like to comment on severe hMPV
infections and to present the case of
a child with fatal acute respiratory dis-
tress syndrome (ARDS) due to infection
with hMPV.
The 20-month-old boy initially pre-
sented with a bronchiolitis-like pattern,
with rhinitis, cough, and increasing
respiratory distress. The child’s history
was unremarkable except for moderate
neurodevelopmental delay of unknown
etiology. Because of impending re-
spiratory failure (capillary pH, 7.17;
partial carbon dioxide pressure, 86 mm
Hg; saturation 83% with 100% oxygen),
he was intubated. The oxygenation index
was 0.32 and the PaO2/FiO2 ratio re-
sulted 68 (55 mm Hg/0.8). On the basis
of radiological findings of bilateral dif-
fuse pulmonary infiltrates, the diagnosis
of ARDS was made. Echocardiography
demonstrated good biventricular func-
tion and no evidence for pulmonary
hypertension. The patient was placed on
high-frequency oscillatory ventilation
(Sensormedics 3100A), with a mean
airway pressure of up to 30 cm water.
Tests for RSV and H1N1 influenza virus
were negative. Results of repeated bac-
terial blood and tracheal fluid cultures
were negative. Therefore, an expanded
panel of respiratory viruses (adenovirus,
picornaviruses, influenzavirus A/B, par-
ainfluenzaviruses 1–3, RSV, and hMPV)
was assessed using direct immunofluo-
rescence. The patient tested positive for
hMPV. Viral testing was repeated several
times and confirmed only infection with
hMPV. Because of the high risk of bac-
terial superinfection, empirical treat-
ment with cefuroxime and vancomycin
was initiated.
The patient subsequently developed
multi-organ failure, with catecholamine-
dependent arterial hypotension, renal
failure requiring continuous renal re-
placement, coagulopathy, thrombocyto-
penia, leukopenia, and hepatitis. Because
oxygenation further deteriorated (oxy-
genation index, .45), venoarterial ex-
tracorporal membrane oxygenation
(ECMO) was initiated. After repeated
failed attempts to wean from ECMO, the
decision to limit treatment was made on
day 18 after admission. The patient died
after cessation of ECMO. The parents
declined an autopsy.
To date, lethal hMPV infections have
been primarily described in im-
munosuppressed adults [3]. hMPV was
first reported in the Netherlands in 2001,
and several studies have shown that the
clinical course of hMPV closely resembles
RSV infection with bronchiolitis, pneu-
monia, and asthma exacerbation as the
main manifestations [2]. In contrast, the
proportion of children with severe hMPV
infection requiring ICU admission or
respiratory support is small [2, 4].
However, infants with RSV and hMPV
coinfection had a 10-fold increased risk
of requiring mechanical ventilation when
compared with infants with isolated RSV
infection [4]. Although ARDS is known
to occur in patients with RSV bronchio-
litis [5], hMPV-associated pediatric
ARDS is very rare. An extensive literature
search resulted in only 4 pediatric pa-
tients with isolated hMPV infection who
developed severe ARDS: a 17-month-old
girl receiving chemotherapy for acute
leukemia died after a prolonged period of
mechanical ventilation [6]. Two other
children, both with underlying diseases
(prematurity with chronic lung disease in
one, transplant-related immunosuppres-
sion in the other), required ECMO but
ultimately recovered [7, 8]. The fourth
reported case concerns a 2 year-old,
previously healthy girl without any
known immunodeficiency who died of
pulmonary hemorrhage soon after ad-
mission [9]. It has been suggested that
deficiencies in innate immunity path-
ways, such as Toll-like receptor 4, lead to
an increased risk of severe RSV infection
[10], but the role of innate immunity in
hMPV infections has not been studied
thus far. The underlying neuro-
developmental delay may represent
a clinical risk factor for severe respiratory
disease in the presented case [2].
In conclusion, the summarized cases
illustrate that hMPV infection may cause
severe ARDS in susceptible children.
Considering that testing for hMPV is not
routinely performed, it is likely that
hMPV-related ARDS is underreported.
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The mortality of pediatric ARDS remains
high and early identification of the
causative agent is crucial. We, therefore,
suggest early testing for hMPV in patients
with presumptive viral ARDS where no
other agent can be identified. Additional
studies investigating the role of hMPV in
severe respiratory infections are needed
to improve early and appropriate treat-
ment of high-risk patients.
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